Results 61 to 70 of about 1,964 (169)

CH50 as a Clinically Useful Biomarker of Disease Activity and Antihistamine Resistance in Chronic Spontaneous Urticaria: An Observational Ambispective Single‐Center Study

open access: yesInternational Journal of Dermatology, Volume 65, Issue 10, Page 2066-2073, October 2026.
Personalized CSU care guided by CH50. ABSTRACT Background Chronic spontaneous urticaria (CSU) is frequently refractory to guideline‐based therapy, highlighting the need for predictive biomarkers. Dysregulation of the complement system has been implicated in CSU severity, but global complement activity has not been systematically evaluated.
Nidia Planella‐Fontanillas   +9 more
wiley   +1 more source

Basophil activation test to BNT162b2 lacks specificity for predicting allergic reactions to the mRNA vaccine

open access: yesJournal of Allergy and Clinical Immunology: Global
Background: Allergic reactions to the coronavirus 2019 disease (COVID-19) mRNA vaccine (BNT162b2) were originally reported at higher rates than expected, contributing to vaccine hesitancy and, in some cases, unnecessary vaccine avoidance.
Sydney Ann Kee, PhD   +8 more
doaj   +1 more source

Basophil Activation Test Provides Additional Diagnostic Value Beyond Ara h 2–Specific IgE Testing in Peanut Allergic Adults

open access: yes
Clinical &Experimental Allergy, EarlyView.
J. S. H. Schaapherder   +7 more
wiley   +1 more source

New Approaches for Basophil Activation Tests Employing Dendrimeric Antigen–Silica Nanoparticle Composites

open access: yesPharmaceutics
In vitro cell activation through specific IgE bound to high-affinity receptors on the basophil surface is a widely used strategy for the evaluation of IgE-mediated immediate hypersensitivity reactions to betalactams.
Silvia Calvo-Serrano   +10 more
doaj   +1 more source

The utility of the basophil activation test in the diagnosis of immediate amoxicillin or amoxicillin-clavulanate hypersensitivity in children and adults

open access: yesItalian Journal of Pediatrics, 2017
Background The basophil activation test (BAT), has been proposed as a possible assay for the diagnosis of immediate-type allergy to beta-lactams (BLs).
Simona Barni   +10 more
doaj   +1 more source

Basophil Activation Test Predicts Cetuximab Anaphylaxis Severity in Alpha-Gal IgE-Positive Patients

open access: yesDiagnostics
Upon first exposure to cetuximab, hypersensitivity reactions can occur. We aimed to assess the utility of the basophil activation test (BAT) to alpha-gal and cetuximab for predicting severe reactions.
Peter Kopač   +8 more
doaj   +1 more source

A Case of Immediate Hypersensitivity Reaction to Maltitol

open access: yesCase Reports in Medicine, 2017
Background. Maltitol is a sugar alcohol that is frequently used as a noncaloric sweetener, although it is also used as an excipient, a plasticizer in gelatin capsules, and an emollient.
Ana Rodríguez Trabado   +4 more
doaj   +1 more source

[A clinical case of occupational allergy to piperacilline. A novel diagnostic method: basophil activation test (BAT)].

open access: yesLa Medicina del lavoro, 2014
Piperacillin, unlike other antibiotics, rarely causes immediate allergic reactions. Only two cases related to occupational exposure are reported in the literature.Adoption of new methods for diagnosis of occupational allergy to drugs.An atopic nurse, aged 30 years, was referred to our hospital for an allergic work-related reaction to piperacillin.
P, Marraccini   +4 more
openaire   +1 more source

Integrated Diagnostic Approach Using Basophil Activation Test and IgE Assays for Shrimp and Prawn Allergy

open access: yesMedicina
Background and Objectives: Shellfish allergies are common in Vietnam. The basophil activation test (BAT) is a powerful tool in the diagnosis of food allergies.
Nhu N. Q. Nguyen   +6 more
doaj   +1 more source

Consideration of the EXiLE test for predicting anaphylaxis after diclofenac etalhyaluronate administration

open access: yesJournal of Immunotoxicology
Diclofenac etalhyaluronate, an active pharmaceutical ingredient in JOYCLU® (JCL), serves as a joint function improvement agent in knee and hip osteoarthritis patients.
Haruyo Akiyama   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy